×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| VENUS REMEDIES LTD. | 1398.5 | 116.9 | 1318.5 | 8.75 | 608.0 | 13.0 |
| KERALA AYURVEDA LTD. | NA | NA | NA | NA | 582 | |
| NECTAR LIFESCIENCES LTD. | 2810.21 | -632.31 | 2806.71 | -2.82 | 519 | 30.5 |
Venus Remedies Ltd., with Security Code 526953, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 148.5 | 98.6 | 170.2 | 131.2 | 175.2 | 105.9 | 167.0 | 172.5 | 194.0 | 131.9 |
| Expenses | 127.5 | 85.2 | 157.1 | 118.2 | 153.9 | 91.6 | 156.8 | 149.6 | 171.4 | 119.2 |
| Operating Profit | 21.0 | 13.5 | 13.1 | 13.0 | 21.3 | 14.3 | 10.3 | 22.9 | 22.6 | 12.7 |
| OPM % | 14.16% | 13.66% | 7.71% | 9.91% | 12.15% | 13.49% | 6.15% | 13.28% | 11.66% | 9.59% |
| Other Income | 3.2 | 2.1 | 2.9 | 2.4 | 3.9 | 1.6 | 10.7 | 11.7 | 6.8 | 8.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 8.1 | 7.3 | 6.2 | 6.3 | 5.7 | 5.8 | 6.2 | 5.2 | 4.5 | 6.0 |
| Profit before tax | 16.2 | 8.2 | 9.9 | 9.1 | 19.5 | 10.1 | 14.8 | 19.5 | 24.9 | 14.7 |
| Tax % | -53.5% | -47.1% | -44.7% | -10.2% | -35.7% | 55.9% | -37.5% | -18% | -28.6% | 20.5% |
| Net Profit | 7.5 | 4.3 | 5.5 | 8.2 | 12.5 | 4.5 | 9.3 | 24.1 | 14.8 | 11.7 |
| EPS in Rs | 5.64 | 3.25 | 4.07 | 6.13 | 9.36 | 3.33 | 6.92 | 18.02 | 0 | 8.75 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.9 | 155.6 | 95.2 | 167.7 | 143.4 | 195.2 | 108.6 | 167.5 | 176.9 | 195.0 |
| Expenses | 108.8 | 131.0 | 84.8 | 149.9 | 131.4 | 175.7 | 97.4 | 162.5 | 158.5 | 165.9 |
| Operating Profit | 8.1 | 24.6 | 10.4 | 17.8 | 12.0 | 19.5 | 11.3 | 4.9 | 18.4 | 29.1 |
| OPM % | 6.93% | 15.81% | 10.93% | 10.61% | 8.39% | 9.98% | 10.37% | 2.94% | 10.38% | 14.92% |
| Other Income | 3.8 | 3.4 | 2.3 | 3.1 | 2.4 | 3.9 | 1.6 | 10.6 | 11.9 | 6.8 |
| Interest | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 7.2 | 8.3 | 7.6 | 6.4 | 6.5 | 5.9 | 6.0 | 6.4 | 5.4 | 4.7 |
| Profit before tax | 4.5 | 19.7 | 5.1 | 14.3 | 7.8 | 17.5 | 6.8 | 9.1 | 15.0 | 31.1 |
| Tax % | -27.5% | -43.9% | -76.6% | -30.7% | -12% | -39.9% | -82.2% | 61.3% | 21.2% | -22.9% |
| Net Profit | 3.3 | 11.1 | 1.2 | 9.9 | 6.9 | 10.5 | 1.2 | 3.5 | 19.6 | 21.0 |
| EPS in Rs | 2.46 | 8.27 | 0.88 | 7.44 | 5.13 | 7.86 | 0.92 | 2.63 | 14.66 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 14% |
| 3 Years: | 4% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 30% |
| 3 Years: | -1% |
| TTM: | 68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 46% |
| 3 Years: | 17% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 13% |
| 3 Years: | 3% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 28% |
| 3 Years: | -10% |
| TTM: | -4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 46% |
| 3 Years: | 17% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|